Le Lézard
Classified in: Health
Subjects: HEALTH, MISCELLANEOUS, MISCELLANEOUS, Contests/Awards

LifeLabs Scores Back-to-Back Win: Named 2024 BrandSpark Most Trusted for Second Consecutive Year


Toronto, Jan. 10, 2024 (GLOBE NEWSWIRE) -- LifeLabs is proud to announce our achievement for the second consecutive year ? securing the 2024 BrandSpark Most Trusted Brand Award in Health Diagnostic Services.

"In the ever-evolving landscape of healthcare, this back-to-back win is a testament to the unwavering commitment of our incredible team. It's not just an award; it's a promise we keep to our community?to be our customer's trusted partner in health," says Charles Brown, President and CEO of LifeLabs.

Over 25,000 voices across Canada chimed in, and LifeLabs emerged as the number one trusted choice for health diagnostic services. Our frontline staff, with their professionalism, helpful attitude, and customer-centric mindset, have turned each visit into a positive experience. 84% of respondents said that LifeLabs has values they identify with, up 4% from last year, citing caring and helpful employees as the main drivers of trust in the LifeLabs brand. This win reaffirms our position as a service provider and an integral part of people's healthcare journeys.

We are grateful for the trust our community has placed in us. Here's to celebrating this win and reclaiming Canadians' number-one choice in health diagnostics. 

Dive into the specifics with the BrandSpark press release here.

About LifeLabs 

LifeLabs is Canada's leading provider of laboratory diagnostic information and digital health connectivity systems, enabling patients and healthcare practitioners to diagnose, treat, monitor, and prevent disease. We support 20 million patient visits annually and conduct over 100 million laboratory tests through leading-edge technologies and our 6,500 talented and dedicated employees. We are a committed innovator in supporting Canadians to live healthier lives, operating Canada's first commercial genetics lab and the country's largest online patient portal, with more than 5 million Canadians receiving their results online. LifeLabs has been named one of Canada's Best Employers (2021, 2022 and 2023) and Best Employers for Diversity (2022 and 2023) by Forbes and recognized for having an award-winning Mental Health Program from Benefits Canada. LifeLabs is 100% Canadian-owned by OMERS Infrastructure, the infrastructure investment manager of one of Canada's largest defined benefit pension plans. Learn more at LifeLabs.com. 



These press releases may also interest you

at 08:10
Final Five-Year Analysis of Phase 3 Data With ADSTILADRIN® (nadofaragene firadenovec-vncg) Shows Durable Bladder Preservation and Consistent Long-Term Safety in BCG-unresponsive NMIBC
Ferring Pharmaceuticals today announced the final 60-month follow-up data from the Phase 3 study of ADSTILADRIN® (nadofaragene firadenovec-vncg) were presented at the American Urological Association (AUA) 2024 Annual Meeting. The study demonstrated...

at 08:10
GE HealthCare to Hold an Investor Day in New York City on November 21, 2024
GE HealthCare , a leader in precision care innovation, will host an investor day on Thursday, November 21, 2024, in New York, NY. GE HealthCare's management team will present its growth strategies, technology portfolio, and vision for its businesses...

at 08:10
Favorable Clinical Data for Applaud Medical's Novel Technology for Treating Urinary Stones Presented During the 2024 AUA Annual Meeting
Applaud Medical, an emerging leader in the treatment of urinary stones, today announced positive results from a prospective, multicenter study of the company's BRIO Enhanced Lithotripsy System (ELS) for the treatment of obstructive ureteral stones....

at 08:10
Outset Medical's TabloCart with Prefiltration Receives FDA 510(k) Clearance
Outset Medical, Inc. ("Outset"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance of...

at 08:10
Results from Pivotal Clinical Study Demonstrate Potential of Nucleix's Bladder EpiCheck® to Improve Disease Recurrence Detection in Non-Muscle Invasive Bladder Cancer (NMIBC) Surveillance
Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, announced that the results from the company's North American pivotal clinical study evaluating the performance of Bladder EpiCheck® as a non-invasive...

at 08:07
La Roche-Posay Kicks Off Skin Cancer Awareness Month with Free Public Skin Cancer Screening in Partnership with The Dermatology Specialists
According to the Melanoma Research Alliance, an estimated 100,640 new cases of invasive melanoma will be diagnosed in the US this year. While this statistic is alarming, skin cancer is preventable; and when detected early, the 5-year survival rate...

More news about Health...


News published on and distributed by: